Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 6—June 2022
Research

Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016

Sarah A. HookComments to Author , Seonghye Jeon, Sara A. Niesobecki, AmberJean P. Hansen, James I. Meek, Jenna K.H. Bjork, Franny M. Dorr, Heather J. Rutz, Katherine A. Feldman, Jennifer L. White, P. Bryon Backenson, Manjunath B. Shankar, Martin I. Meltzer, and Alison F. Hinckley
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (S.A. Hook, A.F. Hinckley); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Jeon, M.B. Shankar, M.I. Meltzer); Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA (S.A. Niesobecki, A.P. Hansen, J.I. Meek); Minnesota Department of Health, St. Paul, Minnesota, USA (J.K.H. Bjork, F.M. Dorr); Maryland Department of Health, Baltimore, Maryland, USA (H.J. Rutz, K.A. Feldman); New York State Department of Health, Albany, New York, USA (J.L. White, P.B. Backenson)

Main Article

Table 5

Societal perspective of total cost of Lyme disease per participant, by disease category, in high-incidence areas, United States, 2014–2016

Disease category
No. participants
Societal perspective, total cost per participant,* 2016 US dollars
Median
Mean
SD
10th percentile
90th percentile
Range
All† 613 690 2,032 6,091 203 4,201 54–122,766
Confirmed localized 273 493 1,307 3,559 154 2,678 54–18,322
Confirmed disseminated 154 1,081 3,251 20,908 297 6,238 216–122,766
Probable 186 940 2,620 15,533 316 5,021 130–105,500

*Total cost per participant according to the societal perspective includes societal medical costs, patient nonmedical costs, and cost of productivity losses. Patient medical costs were not added because they are already included in societal medical costs. †Estimates for the overall population use the sample-weighted data except the range.

Main Article

Page created: April 03, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external